Processa Pharmaceuticals, Inc. Common Stock, Value, Issued
Processa Pharmaceuticals, Inc. (PCSA) had Common Stock, Value, Issued of $279 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $279.00.
- 2026-03-31: Common Stock, Value, Issued $269.00.
- 2025-12-31: Common Stock, Value, Issued $257.00.
- 2025-09-30: Common Stock, Value, Issued $5.29K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $279.00 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $269.00 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $257.00 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $5.29K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.03K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $527.00 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $15.00 10-K · filed 2026-03-18 | $371.00 10-K · filed 2025-03-20 |
| 2024-09-30 | $327.00 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $287.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $286.00 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $129.00 10-K · filed 2025-03-20 | |
| 2023-09-30 | $2.47K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.46K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.46K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $80.00 10-K · filed 2024-03-29 | $1.61K 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.60K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.59K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.59K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.57K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.56K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.56K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.55K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.42K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $577.00 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $552.00 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $549.00 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $549.00 10-K · filed 2021-03-25 | |
| 2019-09-30 | $3.84K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.87K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.87K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $552.00 10-K · filed 2020-03-06 | $3.87K 10-K · filed 2019-03-28 |
| 2018-09-30 | $3.87K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $3.87K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.53K 10-Q · filed 2018-05-21 | |
| 2017-12-31 | $3.53K 10-K/A · filed 2019-04-08 | |
| 2017-09-30 | $2.47K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $1.10K 10-Q · filed 2017-10-04 | |
| 2017-03-31 | $1.10K 10-Q · filed 2017-10-04 | |
| 2016-12-31 | $3.17K 10-K · filed 2018-04-16 | $1.10K 10-K · filed 2017-09-25 |
| 2016-09-30 | $1.10K 10-Q · filed 2017-09-08 | |
| 2016-06-30 | $1.10K 10-Q · filed 2017-08-30 | |
| 2016-03-31 | $1.10K 10-Q · filed 2017-08-07 | |
| 2015-12-31 | $1.10K 10-K · filed 2017-09-25 | |
| 2015-09-30 | $1.10K 10-Q · filed 2015-12-01 | |
| 2015-06-30 | $1.10K 10-Q · filed 2015-08-19 | |
| 2015-03-31 | $1.10K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.09K 10-K · filed 2017-06-19 | |
| 2014-09-30 | $843.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $843.00 10-Q · filed 2014-08-19 | |
| 2014-03-31 | $827.00 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $808.00 10-K · filed 2015-04-14 | |
| 2013-09-30 | $805.00 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $703.00 10-Q/A · filed 2013-09-06 | |
| 2012-12-31 | $190.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |